BRPI0406552A - Uso de l-carnitina para o tratamento de doenças cardiovasculares - Google Patents
Uso de l-carnitina para o tratamento de doenças cardiovascularesInfo
- Publication number
- BRPI0406552A BRPI0406552A BR0406552-2A BRPI0406552A BRPI0406552A BR PI0406552 A BRPI0406552 A BR PI0406552A BR PI0406552 A BRPI0406552 A BR PI0406552A BR PI0406552 A BRPI0406552 A BR PI0406552A
- Authority
- BR
- Brazil
- Prior art keywords
- carnitine
- treatment
- per day
- myocardial infarction
- grams per
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 4
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 229960001518 levocarnitine Drugs 0.000 title 1
- 206010000891 acute myocardial infarction Diseases 0.000 abstract 2
- 230000034994 death Effects 0.000 abstract 1
- 231100000517 death Toxicity 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000178A ITRM20030178A1 (it) | 2003-04-17 | 2003-04-17 | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
| PCT/IT2004/000107 WO2004091602A1 (en) | 2003-04-17 | 2004-03-03 | Use of l-carnitine for the treatment of cardiovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0406552A true BRPI0406552A (pt) | 2005-12-20 |
Family
ID=29765768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0406552-2A BRPI0406552A (pt) | 2003-04-17 | 2004-03-03 | Uso de l-carnitina para o tratamento de doenças cardiovasculares |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060052450A1 (enExample) |
| EP (1) | EP1613301A1 (enExample) |
| JP (1) | JP2006523685A (enExample) |
| KR (1) | KR20050121196A (enExample) |
| CN (2) | CN101467992A (enExample) |
| AU (2) | AU2004229256A1 (enExample) |
| BR (1) | BRPI0406552A (enExample) |
| CA (1) | CA2508636A1 (enExample) |
| IT (1) | ITRM20030178A1 (enExample) |
| MX (1) | MXPA05007612A (enExample) |
| WO (1) | WO2004091602A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040346A1 (it) | 2004-07-13 | 2004-10-13 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
| US20070260674A1 (en) * | 2006-05-02 | 2007-11-08 | Research In Motion Limited | Push framework for delivery of dynamic mobile content |
| CA2719940A1 (en) * | 2008-03-26 | 2009-11-26 | Orthologic Corp. | Methods for treating acute myocardial infarction |
| EP2353596A1 (en) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| CA2834173A1 (en) | 2011-05-03 | 2012-11-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composition useful for the treatment of lipid metabolism disorders |
| CN114073705B (zh) * | 2020-08-14 | 2026-03-10 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种降尿酸药物组合物及其应用 |
| CN112180013B (zh) * | 2020-09-29 | 2022-11-15 | 上海脉示生物技术有限公司 | 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS531812B2 (enExample) * | 1972-12-07 | 1978-01-23 | ||
| AU1295700A (en) * | 1998-11-26 | 2000-06-13 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia |
-
2003
- 2003-04-17 IT IT000178A patent/ITRM20030178A1/it unknown
-
2004
- 2004-03-03 AU AU2004229256A patent/AU2004229256A1/en not_active Withdrawn
- 2004-03-03 BR BR0406552-2A patent/BRPI0406552A/pt not_active IP Right Cessation
- 2004-03-03 US US10/538,868 patent/US20060052450A1/en not_active Abandoned
- 2004-03-03 MX MXPA05007612A patent/MXPA05007612A/es active IP Right Grant
- 2004-03-03 KR KR1020057013711A patent/KR20050121196A/ko not_active Ceased
- 2004-03-03 EP EP04716692A patent/EP1613301A1/en not_active Ceased
- 2004-03-03 JP JP2006507635A patent/JP2006523685A/ja active Pending
- 2004-03-03 CN CNA2008101490996A patent/CN101467992A/zh active Pending
- 2004-03-03 CN CNA2004800015143A patent/CN1717232A/zh active Pending
- 2004-03-03 CA CA002508636A patent/CA2508636A1/en not_active Abandoned
- 2004-03-03 WO PCT/IT2004/000107 patent/WO2004091602A1/en not_active Ceased
-
2010
- 2010-06-14 AU AU2010202396A patent/AU2010202396A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1613301A1 (en) | 2006-01-11 |
| CN1717232A (zh) | 2006-01-04 |
| US20060052450A1 (en) | 2006-03-09 |
| ITRM20030178A0 (it) | 2003-04-17 |
| AU2010202396A1 (en) | 2010-07-01 |
| JP2006523685A (ja) | 2006-10-19 |
| AU2004229256A1 (en) | 2004-10-28 |
| WO2004091602A1 (en) | 2004-10-28 |
| CA2508636A1 (en) | 2004-10-28 |
| MXPA05007612A (es) | 2005-09-30 |
| KR20050121196A (ko) | 2005-12-26 |
| ITRM20030178A1 (it) | 2004-10-18 |
| CN101467992A (zh) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Angulo et al. | Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid | |
| KR102376794B1 (ko) | 담즙정체성 소양증의 치료 | |
| CU23468B7 (es) | Forma de dosificación de pramipexol en una dosis única diaria | |
| EP1369119B1 (en) | Il-12 expression controlling agents | |
| BR0008969A (pt) | Cloreto den-[2-hidróxi-3-(1-piperidinil)-(propóxi]piridina-1-óxido-3-carboximidoìla e seu uso no tratamento deresistência à insulina | |
| BRPI0408295A (pt) | uso de um composto | |
| PE20241327A1 (es) | Tratamiento de trastornos hepaticos con un agonista del thr-beta | |
| PL360492A1 (en) | Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| BR0308038A (pt) | Ambroxol para o tratamento de estados doloridos na cavidade bucal e faringe | |
| BR0316131A (pt) | Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas por agentes anti-câncer | |
| BR0308045A (pt) | Aplicação de 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-onas substituìdas para a preparação de medicamentos com efeito inibidor na lipase pancreática | |
| MXPA05007612A (es) | Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares. | |
| AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
| IE851848L (en) | Propiophenone compound against sexual dysfunction | |
| US20120189600A1 (en) | Compositions and methods for treating neurodegenerative diseases | |
| PT786998E (pt) | A utilizacao de ¬r-(z)|-alfa-(metoxiimino)-alfa-(1-azabiciclo-¬2.2.2|-oct-3-il) acetonitrilo para reduzir a formacao de beta amiloide a4 na doenca de alzheimer | |
| CN119632973A (zh) | 漆黄素制备治疗心脏有关疾病的药物中的应用 | |
| EA200800071A1 (ru) | Производные бензофуранила как ингибиторы 5-нт6-рецептора | |
| KR20080028389A (ko) | 양극성 장애를 치료하기 위한 약제의 수득에 있어서의아고멜라틴의 용도 | |
| BRPI0413750A (pt) | uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit | |
| BRPI0513303A8 (pt) | Uso de l-carnitina para o tratamento de doenças cardiovasculares | |
| CY1114250T1 (el) | Ακετυλ l-καρνιτινη για την προληψη της επιπονης περιφερικης διαβητικης νευροπαθειας | |
| ES2938080T3 (es) | N,N-bis-2-mercaptoetil isoftalamida para el tratamiento de enfermedades neurodegenerativas | |
| PT1769798E (pt) | Nova associação entre a agomelatina e um inibidor da recaptação da noradrenalina e as composições farmacêuticas que a contenham |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |